The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sundstedt, A.
Right arrow Articles by Dohlsten, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sundstedt, A.
Right arrow Articles by Dohlsten, M.

The Journal of Immunology, Vol 154, Issue 12 6306-6313, Copyright © 1995 by American Association of Immunologists


ARTICLES

Superantigen-induced anergy in cytotoxic CD8+ T cells

A Sundstedt, I Hoiden, J Hansson, G Hedlund, T Kalland and M Dohlsten
Pharmacia Oncology Immunology, Lund, Sweden.

This study describes the use of bacterial superantigens to investigate the mechanisms governing peripheral tolerance in CD8+ T cells. Administration of superantigens to mice activates T cells to proliferation, cytokine production, and cytotoxicity, but responding cells subsequently enter a state of hyporesponsiveness or are deleted. Superantigen-induced inactivation has so far mainly been demonstrated for CD4+ T cells. Injection of amounts of the superantigen staphylococcal enterotoxin A (SEA) that are optimal for T cell activation and which induce anergy in CD4+ T cells result in preserved responsiveness in CD8+ CTLs. In contrast, we found that intravenous injection of low concentrations of SEA induced a profound down- regulation of the cytotoxic function in SEA-reactive CD8+ TCR V beta 11+ T cells. No reduction in the number of CD8+V beta 11+ T cells was found, suggesting that anergy and not deletion is the main mechanism for the observed cytotoxic hyporesponsiveness. The cytotoxic anergy was evident 2 days after low-dose priming and remained present 4 wk later, indicating a rapid induction phase and long-lasting persistence. The anergized CD8+ T cell subset expressed lower levels of the alpha- (CD11a) chain of the cell adhesion molecule lymphocyte function- associated Ag 1 (LFA-1) and failed to mediate cytotoxicity, but retained the capacity to proliferate, express IL-2R, produce IFN-gamma, and express granzyme mRNA, which imply a partial defect in TCR- transduced signals. Taken together, these findings suggest that there is a biphasic stimulus-dependent threshold for acquiring responsiveness or anergy in CD8+ T cells.


This article has been cited by other articles:


Home page
CVIHome page
S. A. Ghanekar, L. E. Nomura, M. A. Suni, L. J. Picker, H. T. Maecker, and V. C. Maino
Gamma Interferon Expression in CD8+ T Cells Is a Marker for Circulating Cytotoxic T Lymphocytes That Recognize an HLA A2-Restricted Epitope of Human Cytomegalovirus Phosphoprotein pp65
Clin. Vaccine Immunol., May 1, 2001; 8(3): 628 - 631.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. J. Miyamoto, E. R. Wann, T. Fowler, E. Duffield, M. Hook, and B. W. McIntyre
Fibronectin Binding Protein A of Staphylococcus aureus Can Mediate Human T Lymphocyte Adhesion and Coactivation
J. Immunol., April 15, 2001; 166(8): 5129 - 5138.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Grundstrom, M. Dohlsten, and A. Sundstedt
IL-2 Unresponsiveness in Anergic CD4+ T Cells Is Due to Defective Signaling Through the Common {gamma}-Chain of the IL-2 Receptor
J. Immunol., February 1, 2000; 164(3): 1175 - 1184.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. T. Nugent, D. J. Morgan, J. A. Biggs, A. Ko, I. M. Pilip, E. G. Pamer, and L. A. Sherman
Characterization of CD8+ T Lymphocytes That Persist After Peripheral Tolerance to a Self Antigen Expressed in the Pancreas
J. Immunol., January 1, 2000; 164(1): 191 - 200.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Shrikant and M. F. Mescher
Control of Syngeneic Tumor Growth by Activation of CD8+ T Cells: Efficacy Is Limited by Migration Away from the Site and Induction of Nonresponsiveness
J. Immunol., March 1, 1999; 162(5): 2858 - 2866.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
W. A. Ferens, W. C. Davis, M. J. Hamilton, Y. H. Park, C. F. Deobald, L. Fox, and G. Bohach
Activation of Bovine Lymphocyte Subpopulations by Staphylococcal Enterotoxin C
Infect. Immun., February 1, 1998; 66(2): 573 - 580.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.